Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-17

Clinical Trial Update: Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial of combination chemotherapy for previously untreated rhabdomyosarcoma (including adult and pediatric patients) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Oncology Group | Conditions: Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma | Phase 3 | Status: COMPLETED